Form 4: VYNE Therapeutics Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Mutya Harsch, Chief Legal Officer and GC of VYNE Therapeutics, disposed of 161 shares to cover tax withholding requirements related to vesting restricted stock units.
Summary
- On April 1, 2024, Mutya Harsch, the Chief Legal Officer and General Counsel of VYNE Therapeutics Inc., disposed of 161 shares of common stock.
- The transaction was executed to satisfy tax withholding requirements related to the vesting of restricted stock units.
- The shares were sold at a price of $3.08 per share.
- Following the transaction, Harsch directly owns 149,274 shares of VYNE Therapeutics Inc.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing reflects a routine transaction for tax purposes and doesn't indicate any strategic shift or concern.
Industry Context
Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This transaction appears to be a standard sale to cover tax obligations, which is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of transaction: Mutya Harsch disposed of 161 shares of VYNE Therapeutics common stock. |
| 04/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.